Modulation of cyclic AMP production by signal transduction pathways in preglomerular microvessels and microvascular smooth muscle cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 349-358

  Jackson, Travis C ^a   Mi, Zaichuan ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,1 DIMETHYLETHYL) 1 (4 METHYLPHENYL) 1H PYRAZOLO[3,4 D]PYRIMIDIN 4 AMINE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BUTANOL; CGP 77675; CYCLIC AMP; DIPHENYLIODONIUM SALT; FASUDIL; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOLIPASE INHIBITOR; PROTEIN KINASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GLOMERULUS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; CYCLIC AMP; ESTRENES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET AGGREGATION INHIBITORS; PYRIMIDINES; PYRROLES; PYRROLIDINONES; RATS; SIGNAL TRANSDUCTION;

EID: 3042635065     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.063081     Document Type: Article

References (41)

1. Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, and Kaibuchi K (1999) The COOH terminus of rho-kinase negatively regulates rho-kinase activity. J Biol Chem 274:32418-32424.
2. Andresen BT, Jackson EK, and Romero GG (2001) Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension 37:635-639.
3. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, and Bunting S (1990) Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255:756-768.
4. Bolz SS, Pieperhoff S, De Wit C, and Pohl U (2000) Intact endothelial and smooth muscle function in small resistance arteries after 48 h in vessel culture. Am J Physiol 279:H1434-H1439.
5. Bushman WA, Wilson LK, Luttrell DK, Moyers JS, and Parsons SJ (1990) Overexpression of c-src enhances beta-adrenergic-induced cAMP accumulation. Proc Natl Acad Sci USA 87:7462-7466.
6. Chatziantoniou C, Ruan X, and Arendshorst WJ (1995) Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 92:2924-2928.
7. Chen YG, Siddhanta A, Austin CD, Hammond SM, Sung TC, Frohman MA, Morris AJ, and Shields D (1997) Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network. J Cell Biol 138:495-504.
8. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, and Connelly PA (1996) Discovery of a novel, potent and src family-selective tyrosine kinase inhibitor. Study of Lck-and FynT-dependent T cell activation, J Biol Chem 271:695-701
9. Hanna IR, Taniyama Y, Szocs K, Rocic P, and Griendling KK (2002) NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4:899-914.
10. Hers I, Tavare JM, and Denton RM (1999) The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity. FEBS Lett 460:433-436.
11. Iannone A, Bini A, Swartz HM, Tomasi A, and Vannini V (1989) Metabolism in rat liver microsomes of the nitroxide spin probe tempol. Biochem Pharm 38:2581-2586.
12. Ii M, Hoshiga M, Fukui R, Negoro N, Nakakoji T, Nishiguchi F, Kohbayashi E, Ishihara T, and Hanafusa T (2001) Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27(Kip1). Cardiovasc Res 52:500-508.
13. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, et al. (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945.
14. Ishikawa Y and Homcy CJ (1997) The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res 80:297-304.
15. Jackson EK and Mi Z (2000) Preglomerular microcirculation expresses the cAMP-adenosine pathway. J Pharmacol Exp Ther 295:23-28.
16. Komalavilas P, Mehta S, Wingard CJ, Dransfield DT, Bhalla J, Woodrum JE, Molinaro JR, and Brophy CM (2001) PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol 91:1819-1827.
17. Kotter K and Klein J (1999) Ethanol inhibits astroglial cell proliferation by disruption of phospholipase D-mediated signaling. J Neurochem 73:2517-2523.
18. Kronemann N, Nockher WA, Busse R, and Schini-Kerth VB (1999) Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression. Br J Pharmacol 126:349-357.
19. Ku WC, Cheng AJ, and Wang TC (1997) Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Commun 241:730-736.
20. Lee SD, Lee BD, Han JM, Kim JH, Kim Y, Suh PG, and Ryu SH (2000) Phospholipase D2 activity suppresses hydrogen peroxide-induced apoptosis in PC12 cells. J Neurochem 75:1053-1059.
21. Lincoln TM and Cornwell TL (1991) Towards an understanding of the mechanism of action of cyclic AMP and cyclic GMP in smooth muscle relaxation. Blood Vessels 28:129-137.
22. Lipskaia L, Pourci ML, Delomenie C, Combettes L, Goudouneche D, Paul JL, Capiod T, and Lompre AM (2003) Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ Res 92:1115-1122.
23. Luttrell DK, Hausdorff WP, Moyers JE, Gilmer TM, Parsons SJ, Caron MG, and Lefkowitz RJ (1992) Overexpression of pp60c-src is associated with altered regulation of adenylyl cyclase. Cell Signal 4:531-541.
24. Majerus PW (1992) Inositol phosphate biochemistry. Annu Rev Biochem 61:225-250.
25. Mokkapatti R, Vyas SJ, Romero GG, Mi Z, Inoue T, Dubey RK, Gillespie DG, Stout AK, and Jackson EK (1998) Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther 287:223-231.
26. Mooradian DL, Fernandes B, Diglio CA, and Lester BR (1995) Angiopeptin (BIM23014C) inhibits vascular smooth muscle cell migration in vitro through a G-protein-mediated pathway and is associated with inhibition of adenylyl cyclase and cyclic AMP accumulation. J Cardiovasc Pharmacol 25:611-618.
27. Newman WH, Castresana MR, Webb JG, and Wang Z (2003) Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J Surg Res 109:57-61.
28. Nilsson UA, Olsson LI, Carlin G, and Bylund-Fellenius AC (1989) Inhibition of lipid peroxidation by spin labels: relationships between structure and function. J Biol Chem 19:11131-11135.
29. Rana RS and Hokin LE (1990) Role of phosphoinositides in transmembrane signaling. Physiol Rev 70:115-164.
30. Schwartz JH (2001) The many dimensions of cAMP signaling. Proc Natl Acad Sci USA 98:13482-13484.
31. Sedding DG, Seay U, Fink L, Heil M, Kummer W, Tillmanns H, and Braun-Dullaeus RC (2003) Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation 108:616-622.
32. Soderling SH and Beavo JA (2000) Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 12:174-179.
33. Sunahara RK, Dessauer CW, and Gilman AG (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol 36:461-480.
34. Tintut Y, Patel J, Parhami F, and Demer LL (2000) Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102:2636-2642.
35. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond) 389:990-994.
36. Venable ME, Bielawska A, and Obeid LM (1996) Ceramide inhibits phospholipase D in a cell-free system. J Biol Chem 271:24800-24805.
37. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J (2000) Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20:940-948.
38. Vlahos CJ, Matter WF, Hui KY, and Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
39. Watts VJ (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther 302:1-7.
40. Wettschureck N and Offermanns S (2002) Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med 80:629-638.
41. Vyas SJ, Mi Z, and Jackson EK (1996) The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J Pharmacol Exp Ther 279:114-149.